We identified three groups of M-genes that can be distinguished by their responsiveness to TGF-β and ZEB1 pathways, and demonstrated the distinct biological impacts of the three M clusters in breast cancer patient survival and cell motility regulation. This evidence concerns the gene TGFB1 and breast carcinoma.